Volume : 12, Issue : 10, October – 2025

Title:

FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF VALGANCICLOVIR HYDROCHLORIDE BY USING NATURAL AND SYNTHETIC POLYMERS

Authors :

Sara Kausar, Dr.Syed Areefulla Hussainy, Dr.Abdul Sayeed, , Dr. Faizan Sayeed

Abstract :

The present study focuses on the formulation and evaluation of sustained release matrix tablets of Valganciclovir Hydrochloride (VH) using both natural and synthetic polymers to enhance therapeutic efficacy and patient compliance. Various formulations were prepared utilizing different concentrations of Hydroxypropyl Methylcellulose (HPMC), Xanthan Gum, and Karaya Gum as matrix-forming agents. The pre-compression parameters including bulk density, tapped density, Carr’s index, Hausner’s ratio, and angle of repose were evaluated and found within acceptable limits, indicating good flow properties. Post-compression studies, such as hardness, thickness, friability, weight variation, and drug content, were also within pharmacopeial standards, confirming the uniformity and mechanical integrity of the tablets. In- vitro drug release studies were carried out for 12 hours using USP dissolution apparatus. Among all formulations, batch VH4 demonstrated a sustained and controlled drug release profile, achieving 99.14% drug release at the end of 12hours, there by considering the optimized formulation. This study concludes that a combination of natural and synthetic polymers can effectively control the release of Valganciclovir Hydrochloride, providing a promising approach for sustained drug delivery.
Keywords: Valganciclovir Hydrochloride, HPMC, Xanthan Gum and Karaya Gum

Cite This Article:

Please cite this article in press Sara Kausar et al., Nasal Spray For Decongestant Therapy, Indo Am. J. P. Sci, 2025; 12(10).

REFERENCES:

1. Altaf AS,Friend DR,MAS Rx and COS Rx.Sustained-Release Technology in Rathbone MJ, Hadgraft J, Robert MS, Modified Release Drug Delivery Technology, Marcell Dekker Inc., New York, 2003; 1: 102-117.
2. ReddyKR.,Mutalik S,ReddyS.AAP SPharm.Sci.Tech.2003;4:19.121-125.
3. Mohammed AD et al. Release of propranolol hydrochloride from matrix tablets containing sodium carboxy methyl cellulose and Hydroxypropyl methyl cellulose. Pharm Dev Tech.1999; 4: 313-324.
4. SalsaT,VeigaF.Drug Develop.IndPharm.1997;23:931.
5. Jantzen GM, Robinson JR, Sustained and controlled-release drug delivery systems, in Banker GS,RhodesCT(Eds.)ModernPharmaceutics,3rdEd,Revised and Expanded, Drugs and the Pharmaceutical Sciences.,Marcell Dekker,Inc.NewYork.1995;72:575- 609.
6. Jantzen GM, Robinson JR. Sustained and Controlled- Release Drug Delivery systems Modern Pharmaceutics, 4thed; 2003; 121: 501-502.
7. LeeBJ,RyuSG,CuiJH, Drug Dev.Ind.Pharm.1999;25:493-501.
8. GwenMJ,Joseph RR,In Banker GS and Rhodes CT,Ed.Modern Pharmaceutics,3rdEd Marcel Dekker Inc. New York. 1996; 72: 575.
9. VidyadharaS, Rao PR,Prasad JA.Indian J Pharm Sci.2004;66:188-192.
10. Bogner RH.Bioavailability and bioequivalence of extended-release oral dosageforms. US Pharmacist. 1997; 22: 3–12.
11. Rogers JD, Kwan KC. Pharmacokinetic requirements for controlled-release dosage forms. In: John Urquhart, ed. Controlled-release Pharmaceuticals. Academy of Pharmaceutical Sciences. American Pharmaceutical Association. 1979: 95–119.
12. Madan PL. Sustained-release drug delivery systems, part II: Pre formulation considerations. Pharm Manu fact. 1985; 2: 41–45.
13. Wani MS,Controlled Release System-AReview,2008;61:56-62.
14. Banker GS, Anderson NR. The Theory and Practice of Industrial Pharmacy: Tablet,Lachman, (3rded) Varghese Publishing House, Bombay. 1990; 3: 293-303.
15. LeeVHL,Controlled Drug Delivery Fundamentals and Applications:Influence of drug properties on design, Marcel Dekker, INC, and NewYork. 1987; 2: 16-29.
16. Manish R,Jayesh P,Siah boomi A R. Hydrophilic Matrices for Oral Extended Release: Influence of Fillers on Drug Release from HPMC Matrices. Pharma Times. 2010; 42(04): 67-73.
17. Kumar K Petal.Innovations in Sustained Release Drug Delivery System and ItsMarket Opportunities. J Chem Pharm Res. 2010; 2 1: 349-360.
18. Brahmankar DM, Sunil B. Jaishwal. “Controlled release medication” chapter 15th in “Bio pharmaceutics and Pharmacokinetics –ATreatise, 1st ed, 2010; 1: 347- 353.
19. Stanley S. Davis, Formulation strategies for abs windows. Drug Discovery Today, 2005; 10: 249-257.
20. Modi SA et al. Sustained Release Drug Delivery System:A Review.Int J Pharma. Res Dev. 2011; 2 (12): 147-160.
21. Lieberman HA, Lachman L, Schwartz JB., Pharmaceutical Dosage Forms: Tablets, 2011; 3 (2): 199-287.
22. Aulton ME. Pharmaceutics:The Science of Dosage Form Design.2005; 2: 296-298.
23. Wise DL.Hand book of Pharmaceutical Controlled Release Technology.Inc.2005;2: 5-24.
24. Jantzen GM, Robinson JR. Sustained and Controlled- Release Drug Delivery systems Modern Pharmaceutics, 4thed; 2011; 121: 501-502.
25. Angilicam Avinash,Chata Aparna,Mallemkondu Balaji,Pothi reddy Suresh Sukhetha, Sangeetham Sujith narayana ,Thalari Sneha. Formulation and Evaluation of Sustained Release Matrix Tablets of Ramipril by using Natural and Synthetic Polymers August 2023| IJIRT | Volume 10 Issue 3.
26. Navdeep Kaur,Mohit Kumar Formulation And Evaluation Of Theophylline Sustained Release Matrix Tablets Using Synthetic Polymers Journal of Applied Pharmaceutical Research 10 (2); 2022: 24 – 31.
27. Arpitha G., Nagesh D. R. and B. Gopalakrishna Formulation and Evaluation Of Sustained Release Matrix TabletsOf Lornoxicam Using Natural and Synthetic Polymers.ejpmr, 2021,8(11), 362-401.
28. Shivani Soni,Vivek Jain,Sunil Kumar Jain,Pushpendra Kumar Khan gar Formulations of sustained release matrix tablets of Furosemide using natural and synthetic polymers Journal of Drug Delivery & Therapeutics. 2021; 11(5):105-109. DDD